Moreover, it is very likely that the systemic enhancement in insulin sensitivity, with increased Akt activity in muscle and adipose tissue in addition to the liver, leads to an overall improved metabolism of C2βD1212A/D1212A mice, which reduces the development of hepatic steatosis as a consequence. Here, AKT1 is linked to fatty liver disease.